Streetbeat News

MLEC

Moolec Science SA

https://moolecscience.com

Industry

Biotechnology

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

Open

0.89

Mkt cap

34M

Volume

12K

High

0.89

P/E Ratio

-4.63

52-wk high

3.25

Low

0.85

Div yield

N/A

52-wk low

0.75

As of April 23, 2024, Moolec Science SA (MLEC) and Yatsen Holding Limited (YSG) are identified as overbought stocks in the consumer staples sector, with RSI values of 71.26 and 79.76 respectively. MLEC received USDA-APHIS approval for its GE soybean, leading to a 106% stock increase over five days. YSG regained NYSE compliance, with its stock up 83% over the past month.

Portfolio Pulse from Avi Kapoor

April 23, 2024 | 11:49 am

U.S. stocks saw gains with the S&P 500 rising over 1%. Zions Bancorporation (ZION) shares increased by 4% after reporting Q1 earnings that exceeded EPS estimates but missed revenue forecasts. Other notable movements included Moolec Science (MLEC), NewGenIvf Group (NIVF), and Matterport (MTTR) experiencing significant gains, while Vaxxinity (VAXX), Hepion Pharmaceuticals (HEPA), and Warrantee (WRNT) saw sharp declines.

Portfolio Pulse from Avi Kapoor

April 22, 2024 | 6:46 pm

Vaxxinity, Inc. announced its intention to voluntarily delist and deregister its Class A common stock, causing a sharp decline in its shares by around 55%. Other stocks experienced significant movements, with Matterport, Inc. seeing a jump due to an acquisition announcement by CoStar Group, and various companies reporting gains due to positive developments such as USDA approvals, IPO pricing, and compliance regains. Conversely, several companies faced declines due to negative news such as wind-down activities, delisting determinations, and price reductions.

Portfolio Pulse from Avi Kapoor

April 22, 2024 | 5:26 pm

U.S. stocks traded higher with the Dow Jones, NASDAQ, and S&P 500 all seeing gains. Albertsons Companies Inc reported upbeat fourth-quarter earnings, while Matterport, Inc announced a significant acquisition deal by CoStar Group, causing its shares to spike. Other notable movements included Moolec Science SA and NewGenIvf Group Limited experiencing substantial share increases, whereas Vaxxinity, Inc, Hepion Pharmaceuticals, Inc, and Warrantee Inc faced sharp declines.

Portfolio Pulse from Avi Kapoor

April 22, 2024 | 4:07 pm

U.S. stocks traded higher with the Dow Jones gaining over 100 points. The Chicago Fed National Activity Index rose to +0.15 in March, exceeding expectations. Moolec Science SA, NewGenIvf Group Limited, and SuperCom Ltd. saw significant stock increases, while Vaxxinity, Inc., Hepion Pharmaceuticals, Inc., and Connexa Sports Technologies Inc. experienced notable declines.

Portfolio Pulse from Avi Kapoor

April 22, 2024 | 1:41 pm

Moolec Science's shares surged 135% following USDA approval for its plant-grown animal proteins. Sea's shares rose 6% after B of A Securities upgraded the stock to Buy and increased the price target. Cherry Hill Mortgage's shares increased 7.5% as the company explores strategic alternatives.

Portfolio Pulse from ryanfaloona@benzinga.com

April 22, 2024 | 12:47 pm

Shares of Moolec Science SA (NASDAQ:MLEC) surged after announcing USDA-APHIS approval for its genetically engineered soybean, Piggy Sooy, which produces animal meat protein. This marks a significant biotechnological milestone, as it's the first product of its kind to receive such approval, indicating it does not pose an increased plant pest risk. The company previously reported high levels of pork protein expression in Piggy Sooy seeds and has patented the technology.

Portfolio Pulse from Shivani Kumaresan

April 22, 2024 | 12:22 pm

Moolec Science shares surged following the announcement of USDA approval for its plant-grown animal proteins, marking a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 11:42 am

Moolec Science (NASDAQ:MLEC) reported Q2 earnings with a loss of $(0.05) per share, surpassing the expected $(0.07) loss. However, their sales of $252.10K fell short of the anticipated $600.00K.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 12:11 pm

Numerous companies are scheduled to report their earnings on March 13, 2024, covering a wide range of industries from biotech to retail. Notable mentions include Dollar Tree with expected earnings of $2.65 per share on $8.67 billion revenue, and Lennar with an estimate of $2.20 per share on $7.39 billion revenue. Several companies are anticipated to report losses, such as ZIM Integrated Shipping with a projected loss of $1.29 per share.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 10:15 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.